(Q35911397)

English

Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

author name string

C Ventika S Ram

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

569-577

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Angiotensin II type 1 receptor blockers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Hypertension in four African-origin populations: current 'Rule of Halves', quality of blood pressure control and attributable risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Angiotensin II receptor antagonists role in arterial hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

The relationships between dose and antihypertensive effect of four AT1-receptor blockers. Differences in potency and efficacy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Low-dose combination therapy: an important first-line treatment in the management of hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

The role of combination therapy in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Angiotensin receptor blockers and diuretics as combination therapy: clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Angiotensin II antagonists for hypertension: are there differences in efficacy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02632.X

21 January 2018

Identifiers

10.1111/J.1524-6175.2004.02632.X

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35911397&oldid=1605245929"